710 related articles for article (PubMed ID: 15504828)
1. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
[TBL] [Abstract][Full Text] [Related]
2. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
[TBL] [Abstract][Full Text] [Related]
3. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Mazzariol A; Koncan R; Vitali LA; Cornaglia G
J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
[TBL] [Abstract][Full Text] [Related]
4. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.
Walsh F; Willcock J; Amyes S
J Antimicrob Chemother; 2003 Sep; 52(3):345-53. PubMed ID: 12917252
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
McGhee P; Clark C; Kosowska-Shick KM; Nagai K; Dewasse B; Beachel L; Appelbaum PC
Antimicrob Agents Chemother; 2010 Jan; 54(1):230-8. PubMed ID: 19884376
[TBL] [Abstract][Full Text] [Related]
6. Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae.
Bogdanovich T; Bozdogan B; Appelbaum PC
Antimicrob Agents Chemother; 2006 Mar; 50(3):893-8. PubMed ID: 16495248
[TBL] [Abstract][Full Text] [Related]
7. Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes.
Nagai K; Davies TA; Ednie LM; Bryskier A; Palavecino E; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2001 Nov; 45(11):3242-5. PubMed ID: 11600391
[TBL] [Abstract][Full Text] [Related]
8. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22.
Reinert RR; Al-Lahham A
Antimicrob Agents Chemother; 2005 Jul; 49(7):3011-3. PubMed ID: 15980387
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.
Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1997 Sep; 41(9):1867-70. PubMed ID: 9303375
[TBL] [Abstract][Full Text] [Related]
10. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.
Pereyre S; Renaudin H; Charron A; Bébéar C; Bébéar CM
J Antimicrob Chemother; 2006 Apr; 57(4):753-6. PubMed ID: 16464889
[TBL] [Abstract][Full Text] [Related]
11. Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides.
Wierzbowski AK; Boyd D; Mulvey M; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2005 Nov; 49(11):4635-40. PubMed ID: 16251306
[TBL] [Abstract][Full Text] [Related]
12. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
Mazzariol A; Koncan R; Bahar G; Cornaglia G
J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
[TBL] [Abstract][Full Text] [Related]
13. Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium.
Van Eldere J; Meekers E; Lagrou K; Massonet C; Canu A; Devenyns I; Verhaegen J; Syrogiannopoulos G; Leclercq R
Clin Microbiol Infect; 2005 Apr; 11(4):332-4. PubMed ID: 15760433
[TBL] [Abstract][Full Text] [Related]
14. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.
Canu A; Malbruny B; Coquemont M; Davies TA; Appelbaum PC; Leclercq R
Antimicrob Agents Chemother; 2002 Jan; 46(1):125-31. PubMed ID: 11751122
[TBL] [Abstract][Full Text] [Related]
15. Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countries.
Nagai K; Appelbaum PC; Davies TA; Kelly LM; Hoellman DB; Andrasevic AT; Drukalska L; Hryniewicz W; Jacobs MR; Kolman J; Miciuleviciene J; Pana M; Setchanova L; Thege MK; Hupkova H; Trupl J; Urbaskova P
Antimicrob Agents Chemother; 2002 Feb; 46(2):371-7. PubMed ID: 11796344
[TBL] [Abstract][Full Text] [Related]
16. Activity of the ketolide telithromycin (HMR-3647) against erythromycin-susceptible and -resistant pneumococci isolated in the UK.
Johnson AP; Henwood CJ; Tysall L; Warner M
Int J Antimicrob Agents; 2001 Jul; 18(1):73-6. PubMed ID: 11463530
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Visalli MA; Jacobs MR; Appelbaum PC
Diagn Microbiol Infect Dis; 1997 Jul; 28(3):131-7. PubMed ID: 9294703
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
Walsh F; Carnegy F; Willcock J; Amyes S
J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
[TBL] [Abstract][Full Text] [Related]
19. Activity of telithromycin and seven other agents against 1034 pediatric Streptococcus pneumoniae isolates from ten central and eastern European centers.
Bozdogan B; Appelbaum PC; Kelly LM; Hoellman DB; Tambic-Andrasevic A; Drukalska L; Hryniewicz W; Hupkova H; Jacobs MR; Kolman J; Konkoly-Thege M; Miciuleviciene J; Pana M; Setchanova L; Trupl J; Urbaskova P
Clin Microbiol Infect; 2003 Jul; 9(7):653-61. PubMed ID: 12925106
[TBL] [Abstract][Full Text] [Related]
20. Relative potency of telithromycin, azithromycin and erythromycin against recent clinical isolates of gram-positive cocci.
Barry AL; Fuchs PC; Brown SD
Eur J Clin Microbiol Infect Dis; 2001 Jul; 20(7):494-7. PubMed ID: 11561807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
